Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms
 

Summary

Company, the leading business intelligence provider, has released its latest research, “Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms”. The report analyzes the markets for veterinary vaccines, covering bovine, ovine, porcine and equine species in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. The report also provides geographical landscape, competitive landscape, product profiles, and analysis on drivers and barriers that impact the veterinary vaccines market. Furthermore, the report provides company profiling, SWOT analysis for the leading companies, and analyzes the mergers, acquisitions, recent activities and licensing agreements that shape the global markets.

Company analyzes the veterinary vaccines market up to 2017. The report examines the market by analyzing livestock species including bovine, ovine, equine and porcine. The target population considered is the total animal population in each respective region. The report specifically covers livestock species excluding companion animals, and concludes that the livestock market sector has shown steady growth in recent years. Biotechnology developments and research contributed tremendously towards the growth and enhancement of the veterinary vaccines market. Europe and the US collectively hold more than 70% of the total market.

The market grew at a steady rate for the past few years and is expected to grow further. The demand for veterinary vaccines in the market is driven by factors such as the vulnerability of animals to fatal and chronic diseases, and the changing patterns of the diseases. The recent epidemics created awareness among livestock owners of the need to avoid the huge production losses due to diseases such as swine flu, avian influenza and anthrax. The future of vaccines will be dominated by DNA-related vaccines and combination vaccines, which can provide protection against various diseases with minimal vaccine shots. Such innovative products will be more capable of providing protection and generating a strong immune response than the traditional vaccines.

The key players in the veterinary vaccines market are Bayer HealthCare, Merck & Co. Inc., Fort Dodge Animal Health, Novartis Animal Heath, Pfizer, Lohmann Animal Health, Merial Ltd., Boehringer Ingelheim GmbH, and Heska Corporation. There are many other companies which are involved with the manufacturing and development of veterinary vaccines apart from those in the list.

Scope

- Annualized market data for the veterinary vaccines market from 2002 to 2010, forecast forward to 2017.
- Analysis of the leading livestock segments, including bovine, ovine, porcine and equine.
- Analysis of the veterinary vaccines market in the leading geographies of the world, which include the US, Europe and Japan.
- Market characterization of the veterinary vaccines market, including market size, annual cost of vaccination and target population.
- Key drivers and barriers that have a significant impact on the market.
- Competitive benchmarking of leading companies. The key companies studied in this report are Bayer, Pfizer, Merck and Novartis.
- Key M&A activities and licensing agreements that have taken place in the veterinary vaccines market.

Reasons to buy

- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading livestock segments and geographic markets poised for strong growth.
- Develop key strategic initiatives by understanding the key focus areas of leading companies and niche companies which are helpful in extending the pipeline portfolio.
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 GBI Research Report Guidance 9
3 Veterinary Vaccines Market to 2017 - Market Overview 10
3.1 Revenue Forecasts 10
3.2 Drivers 11
3.2.1 Livestock Owners Developing Increased Disease Awareness for Farm Animals 11
3.3 Barriers 11
3.3.1 Mutant Strains of Virus Pose a Challenge in Vaccine Manufacturing 11
3.3.2 Decrease in Cattle Population is Reducing the Demand for Vaccines 11
4 Veterinary Vaccines Market to 2017 - Geographical Landscape 12
4.1 The US 12
4.1.1 Revenue Forecast 12
4.2 Europe 13
4.2.1 Revenue Forecast 13
4.3 Japan 14
4.3.1 Revenue Forecast 14
5 Veterinary Vaccines Market to 2017 - Bovine Vaccines Market 15
5.1 The US 15
5.1.1 Revenue Forecasts 15
5.1.2 Annual Cost of Vaccination 16
5.1.3 Target Population 17
5.2 Europe 18
5.2.1 Revenue Forecasts 18
5.2.2 Annual Cost of Vaccination 19
5.2.3 Target Population 20
5.3 Japan 21
5.3.1 Revenue Forecasts 21
5.3.2 Annual Cost of Vaccination 22
5.3.3 Target Population 23
6 Veterinary Vaccines Market to 2017 - Ovine Vaccines Market 24
6.1 The US (Sheep Vaccines Market) 24
6.1.1 Revenue Forecasts 24
6.1.2 Annual Cost of Vaccination 25
6.1.3 Target Population 26
6.2 Europe (Sheep Vaccine Market) 27
6.2.1 Revenue Forecasts 27
6.2.2 Annual Cost of Vaccination 28
6.2.3 Target Population 29
6.3 Japan (Sheep Vaccines Market) 30
6.3.1 Revenue Forecasts 30
6.3.2 Annual Cost of Vaccination 31
6.3.3 Target Population 32
6.4 The US (Goat Vaccines Market) 33
6.4.1 Revenue Forecasts 33
6.4.2 Annual Cost of Vaccination 34
6.4.3 Target Population 35
6.5 Europe (Goat Vaccines Market) 36
6.5.1 Revenue Forecasts 36
6.5.2 Annual Cost of Vaccination 37
6.5.3 Target Population 38
6.6 Japan (Goat Vaccines Market) 39
6.6.1 Revenue Forecasts 39
6.6.2 Annual Cost of Vaccination 40
6.6.3 Target Population 41
7 Veterinary Vaccines Market to 2017 - Porcine Vaccines Market 42
7.1 The US 42
7.1.1 Revenue Forecasts 42
7.1.2 Annual Cost of Vaccination 43
7.1.3 Target Population 44
7.2 Europe 45
7.2.1 Revenue Forecasts 45
7.2.2 Annual Cost of Vaccination 46
7.2.3 Target Population 47
7.3 Japan 48
7.3.1 Revenue Forecasts 48
7.3.2 Annual Cost of Vaccination 49
7.3.3 Target Population 50
8 Veterinary Vaccines Market to 2017 - Equine Vaccines Market 51
8.1 The US 51
8.1.1 Revenue Forecasts 51
8.1.2 Annual Cost of Vaccination 52
8.1.3 Target Population 53
8.2 Europe 54
8.2.1 Revenue Forecasts 54
8.2.2 Annual Cost of Vaccination 55
8.2.3 Target Population 56
8.3 Japan 57
8.3.1 Revenue Forecasts 57
8.3.2 Annual Cost of Vaccination 58
8.3.3 Target Population 59
9 Veterinary Vaccines Market to 2017 - Competitive Landscape 60
9.1 Company Profiles 60
9.1.1 Bayer HealthCare 60
9.1.2 Pfizer 60
9.1.3 Merck Inc. 62
9.1.4 Novartis 63
10 Veterinary Vaccines Market to 2017 - Product Profiles 64
10.1 Bovine Vaccines 64
10.1.1 Alpha-7 64
10.1.2 Vira Shield 6 + VL5 64
10.1.3 Salmonella Newport Bacterial Extract SRP 64
10.1.4 Imrab Large Animal 65
10.1.5 Anthrax Spore Vaccine 65
10.1.6 J-5 E. Coli Bacterin 65
10.2 Ovine Vaccines 66
10.2.1 Ultrabac 7 66
10.2.2 Ultrabac CD 66
10.2.3 Clostri Shield 7 66
10.3 Porcine Vaccines 67
10.3.1 Parvo Shield L5E 67
10.3.2 Porcine Pili Shield+C 67
10.3.3 LitterGuard LT-C 67
10.3.4 Farrowsure Gold B 67
10.4 Equine Vaccines 68
10.4.1 Recombitek Equine West Nile Virus Vaccine 68
10.4.2 Fluvac Innovator 6 68
10.4.3 Prestige V + VEE 68
10.4.4 Potomavac 69
10.4.5 Imrab 3 69
11 Veterinary Vaccines Market to 2017 - Mergers & Acquisitions 70
11.1 Phibro Animal Health Completed Acquisition of Abic Animal Health in February 2009 70
11.2 Ceva Acquired Vetech Laboratories in October 2011 70
11.3 Ceva Acquired CentaurVA Animal Health in October 2011 70
11.4 Harbin Pharma Acquired Pfizer’s Swine Vaccine Business in June 2010 70
11.5 Boehringer Ingelheim Animal Health Acquires a Significant Portion of the Fort Dodge Animal Health Business from Pfizer in October 2009 70
11.6 Pfizer Acquired Microtek International in May 2010 70
11.7 Virbac Acquired Certain Veterinary Products from Pfizer in February 2010 70
12 Veterinary Vaccines Market to 2017 - Licensing Agreements 71
12.1 Heska Corporation Amends Bovine Vaccine Agreement with AgriLabs 71
12.2 Pfizer Animal Health Inks Global Licensing Deal with Epitopix 71
12.3 GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD Vaccine 71
12.4 Vical Enters into Agreement with Japanese Partner for Veterinary Pandemic Influenza Vaccine 71
13 Veterinary Vaccines Market to 2017 - Recent Activities 72
13.1 Intervet’s Equine West Nile Vaccine Approved by USDA (United States Department of Agriculture) 72
13.2 Defra Launched Bovine Tuberculosis Vaccine 72
13.3 Boehringer Ingelheim Vetmedica Receives Approval for Express FP and Express Vaccines from the USDA 72
14 Veterinary Vaccines Market to 2017 - Appendix 73
14.1 Market Definitions 73
14.2 Abbreviations 73
14.3 Research Methodology 73
14.3.1 Coverage 73
14.3.2 Secondary Research 74
14.3.3 Primary Research 74
14.4 Therapeutic Landscape 75
14.4.1 Market Size by Geography 75
14.5 Geographical Landscape 75
14.6 Competitive Landscape 75
14.6.1 Expert Panel Validation 75
14.7 Contact Us 75
14.8 Disclaimer 76
14.9 Sources 76

1.1 List of Tables

Table 1: Veterinary Vaccines Market to 2017, Global, Revenues ($bn), 2002–2010 10
Table 2: Veterinary Vaccines Market to 2017, Global, Revenue Forecast ($bn), 2010–2017 10
Table 3: Veterinary Vaccines Market to 2017, The US, Revenues ($m), 2002–2010 12
Table 4: Veterinary Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 12
Table 5: Veterinary Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 13
Table 6: Veterinary Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 13
Table 7: Veterinary Vaccines Market to 2017, Japan, Revenues ($m), 2002–2010 14
Table 8: Veterinary Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010–2017 14
Table 9: Bovine Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 15
Table 10: Bovine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 15
Table 11: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2002–2010 16
Table 12: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2010–2017 16
Table 13: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2002–2010 17
Table 14: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2010–2017 17
Table 15: Bovine Vaccines Market to 2017, Europe, Revenues ($m), 2002–2010 18
Table 16: Bovine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 18
Table 17: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 19
Table 18: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 19
Table 19: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2002–2010 20
Table 20: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2010–2017 20
Table 21: Bovine Vaccines Market to 2017, Japan, Revenue ($m), 2002–2010 21
Table 22: Bovine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010–2017 21
Table 23: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 22
Table 24: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 22
Table 25: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2002–2010 23
Table 26: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2010–2017 23
Table 27: Sheep Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 24
Table 28: Sheep Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 24
Table 29: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2010 25
Table 30: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010–2017 25
Table 31: Sheep Vaccines Market to 2017, The US, Target Population (million), 2002–2010 26
Table 32: Sheep Vaccines Market to 2017, The US, Target Population (million), 2010–2017 26
Table 33: Sheep Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 27
Table 34: Sheep Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 27
Table 35: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 28
Table 36: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 28
Table 37: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2002–2010 29
Table 38: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2010–2017 29
Table 39: Sheep Vaccines Market to 2017, Japan, Revenue ($), 2002–2010 30
Table 40: Sheep Vaccines Market to 2017, Japan, Revenue Forecast ($), 2010–2017 30
Table 41: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 31
Table 42: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 31
Table 43: Sheep Vaccines Market to 2017, Japan, Target Population, 2002–2010 32
Table 44: Sheep Vaccines Market to 2017, Japan, Target Population, 2010–2017 32
Table 45: Goat Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 33
Table 46: Goat Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 33
Table 47: Goat Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2010 34
Table 48: Goat Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010–2017 34
Table 49: Goat Vaccines Market to 2017, The US, Target Population (million), 2002–2010 35
Table 50: Goat Vaccines Market to 2017, The US, Target Population (million), 2010–2017 35
Table 51: Goat Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 36
Table 52: Goat Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 36
Table 53: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 37
Table 54: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 37
Table 55: Goat Vaccines Market to 2017, Europe, Target Population (million), 2002–2010 38
Table 56: Goat Vaccines Market to 2017, Europe, Target Population (million), 2010–2017 38
Table 57: Goat Vaccines Market to 2017, Japan, Revenue, $000’s, 2002–2010 39
Table 58: Goat Vaccines Market to 2017, Japan, Revenue Forecast, $000’s, 2010–2017 39
Table 59: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 40
Table 60: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 40
Table 61: Goat Vaccines Market to 2017, Japan, Target Population, 2002–2010 41
Table 62: Goat Vaccines Market to 2017, Japan, Target Population, 2010–2017 41
Table 63: Porcine Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 42
Table 64: Porcine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 42
Table 65: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2010 43
Table 66: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010–2017 43
Table 67: Porcine Vaccines Market to 2017, The US, Target Population (million), 2002–2010 44
Table 68: Porcine Vaccines Market to 2017, The US, Target Population (million), 2010–2017 44
Table 69: Porcine Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 45
Table 70: Porcine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 45
Table 71: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 46
Table 72: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 46
Table 73: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2002–2010 47
Table 74: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2010–2017 47
Table 75: Porcine Vaccines Market to 2017, Japan, Revenue ($m), 2002–2010 48
Table 76: Porcine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010–2017 48
Table 77: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 49
Table 78: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 49
Table 79: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2002–2010 50
Table 80: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2010–2017 50
Table 81: Equine Vaccines Market to 2017, The US, Revenue ($m), 2002–2010 51
Table 82: Equine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010–2017 51
Table 83: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2010 52
Table 84: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010–2017 52
Table 85: Equine Vaccines Market to 2017, The US, Target Population (000’s), 2002–2010 53
Table 86: Equine Vaccines Market to 2017, The US, Target Population (000’s), 2010–2017 53
Table 87: Equine Vaccines Market to 2017, Europe, Revenue ($m), 2002–2010 54
Table 88: Equine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010–2017 54
Table 89: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2010 55
Table 90: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010–2017 55
Table 91: Equine Vaccines Market to 2017, Europe, Target Population, 000’s, 2002–2010 56
Table 92: Equine Vaccines Market to 2017, Europe, Target Population, 000’s, 2010–2017 56
Table 93: Equine Vaccines Market to 2017, Japan, Revenue ($m), 2002–2010 57
Table 94: Equine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010–2017 57
Table 95: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2010 58
Table 96: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010–2017 58
Table 97: Equine Vaccines Market to 2017, Japan, Target Population, 000’s, 2002–2010 59
Table 98: Equine Vaccines Market to 2017, Japan, Target Population, 000’s, 2010–2017 59
Table 99: Veterinary Vaccines Market to 2017, Product Portfolio, Bayer HealthCare, 2011 60
Table 100:Veterinary Vaccines Market to 2017, Product Portfolio, Pfizer Animal Health, 2011 61
Table 101:Veterinary Vaccines Market to 2017, Product Portfolio, Merck Inc., 2011 62

1.2 List of Figures

Figure 1: Veterinary Vaccines Market to 2017, Global, Revenue Forecast ($bn), 2002–2017 10
Figure 2: Veterinary Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 12
Figure 3: Veterinary Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 13
Figure 4: Veterinary Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002–2017 14
Figure 5: Bovine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 15
Figure 6: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2002–2017 16
Figure 7: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2002–2017 17
Figure 8: Bovine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 18
Figure 9: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 19
Figure 10: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2002–2017 20
Figure 11: Bovine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002–2017 21
Figure 12: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($),2002–2017 22
Figure 13: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2002–2017 23
Figure 14: Sheep Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 24
Figure 15: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2017 25
Figure 16: Sheep Vaccines Market to 2017, The US, Target Population (million), 2002–2017 26
Figure 17: Sheep Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 27
Figure 18: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 28
Figure 19: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2002–2017 29
Figure 20: Sheep Vaccines Market to 2017, Japan, Revenue Forecast ($), 2002–2017 30
Figure 21: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2017 31
Figure 22: Sheep Vaccines Market to 2017, Japan, Target Population, 2002–2017 32
Figure 23: Goat Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 33
Figure 24: Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2017 34
Figure 25: Goat Vaccines Market to 2017, The US, Target Population (million), 2002–2017 35
Figure 26: Goat Vaccines Market to 2017, Europe, Revenue ($m), 2002–2017 36
Figure 27: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 37
Figure 28: Goat Vaccines Market to 2017, Europe, Target Population (million), 2002–2017 38
Figure 29: Goat Vaccines Market to 2017, Japan, Revenue Forecast, $000’s, 2002–2017 39
Figure 30: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2017 40
Figure 31: Goat Vaccines Market to 2017, Japan, Target Population, 2002–2017 41
Figure 32: Porcine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 42
Figure 33: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2017 43
Figure 34: Porcine Vaccines Market to 2017, The US, Target Population (million), 2002–2017 44
Figure 35: Porcine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 45
Figure 36: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 46
Figure 37: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2002–2017 47
Figure 38: Porcine Vaccines Market to 2017, Japan, Revenue ($m), 2002–2017 48
Figure 39: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002–2017 49
Figure 40: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2002–2017 50
Figure 41: Equine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002–2017 51
Figure 42: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002–2017 52
Figure 43: Equine Vaccines Market to 2017, The US, Target Population (000’s), 2002–2017 53
Figure 44: Equine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002–2017 54
Figure 45: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002–2017 55
Figure 46: Equine Vaccines Market to 2017, Europe, Target Population, 000’s, 2002–2017 56
Figure 47: Equine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002–2017 57
Figure 48: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2017 58
Figure 49: Equine Vaccines Market to 2017, Japan, Target Population, 000’s, 2002–2017 59

Companies Menstion

Bayer HealthCare
Pfizer
Merck Inc.
Novartis